CIBC Asset Management
GSK icon

CIBC Asset Management’s GSK GSK Stock Holding History

CIBC Asset Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.07M Buy
+20,474
New +$1.08M ﹤0.01% 722
2026
Q1 		– Sell
-51,146
Closed -$2.51M – 1402
2025
Q4 		$2.51M Sell
51,146
-24,887
-33% -$1.16M 0.01% 606
2025
Q3 		$3.28M Sell
76,033
-1,355
-2% -$52.9K 0.01% 489
2025
Q2 		$2.97M Buy
+77,388
New +$2.96M 0.01% 497
2022
Q2 		– Sell
-4,004
Closed -$218K – 1359
2022
Q1 		$218K Buy
+4,004
New +$217K ﹤0.01% 1313
2020
Q4 		– Sell
-98,554
Closed -$4.61M – 1251
2020
Q3 		$4.61M Sell
98,554
-25,761
-21% -$1.29M 0.02% 292
2020
Q2 		$6.31M Sell
124,315
-19,672
-14% -$1.01M 0.04% 233
2020
Q1 		$6.79M Sell
143,987
-3,055
-2% -$163K 0.05% 212
2019
Q4 		$8.61M Sell
147,042
-4,124
-3% -$229K 0.05% 169
2019
Q3 		$8.04M Sell
151,166
-19,927
-12% -$1.03M 0.05% 174
2019
Q2 		$8.54M Sell
171,093
-14,743
-8% -$740K 0.05% 160
2019
Q1 		$9.68M Buy
185,836
+120,436
+184% +$6.02M 0.06% 145
2018
Q4 		$3.1M Sell
65,400
-68,423
-51% -$3.37M 0.02% 286
2018
Q3 		$6.7M Sell
133,823
-6,120
-4% -$311K 0.04% 181
2018
Q2 		$7.03M Sell
139,943
-7,088
-5% -$357K 0.04% 172
2018
Q1 		$7.16M Buy
147,031
+71,239
+94% +$3.32M 0.05% 165
2017
Q4 		$3.35M Sell
75,792
-25,400
-25% -$1.17M 0.02% 298
2017
Q3 		$5.12M Buy
101,192
+28,888
+40% +$1.47M 0.03% 215
2017
Q2 		$3.87M Buy
72,304
+6,056
+9% +$323K 0.03% 257
2017
Q1 		$3.48M Buy
66,248
+5,672
+9% +$288K 0.02% 271
2016
Q4 		$2.9M Sell
60,576
-23,232
-28% -$1.15M 0.02% 304
2016
Q3 		$4.5M Sell
83,808
-7,728
-8% -$424K 0.03% 219
2016
Q2 		$4.93M Sell
91,536
-6,128
-6% -$323K 0.04% 202
2016
Q1 		$4.93M Sell
97,664
-4,168
-4% -$208K 0.04% 192
2015
Q4 		$5.11M Buy
101,832
+1,056
+1% +$53.8K 0.04% 180
2015
Q3 		$4.81M Buy
100,776
+2,508
+3% +$131K 0.04% 189
2015
Q2 		$5.09M Buy
98,268
+14,572
+17% +$820K 0.04% 197
2015
Q1 		$4.8M Buy
83,696
+572
+0.7% +$32.8K 0.03% 200
2014
Q4 		$4.43M Buy
83,124
+7,176
+9% +$401K 0.03% 204
2014
Q3 		$4.35M Buy
75,948
+10,968
+17% +$672K 0.03% 233
2014
Q2 		$4.34M Buy
64,980
+10,576
+19% +$716K 0.02% 250
2014
Q1 		$3.62M Sell
54,404
-944
-2% -$63.8K 0.02% 273
2013
Q4 		$3.69M Sell
55,348
-3,336
-6% -$216K 0.02% 259
2013
Q3 		$3.68M Buy
+58,684
New +$3.78M 0.02% 252

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

CIBC Asset Management's GSK Position: Q2 2026 in Review

CIBC Asset Management opened a new position in GSK (GSK) in Q2 2026: 20,474 shares worth $1.07M. The stake represents ﹤0.01% of the portfolio and ranks #722 among its holdings. This is a return to the name: CIBC Asset Management previously reported a position in GSK as recently as Q4 2025.

CIBC Asset Management first reported a position in GSK in Q3 2013 and has held it in 34 quarters since. The position peaked at $9.68M in Q1 2019. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • CIBC Asset Management held 20,474 shares of GSK worth $1.07M as of Q2 2026.
  • GSK was a new CIBC Asset Management position in Q2 2026.
  • GSK made up ﹤0.01% of CIBC Asset Management's portfolio in Q2 2026, its #722 holding.
  • CIBC Asset Management first reported a position in GSK in Q3 2013 and has held it in 34 quarters since.
  • CIBC Asset Management's GSK position peaked at $9.68M in Q1 2019.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on CIBC Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.